Back to trial detailsIntake questionnaire
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Applying to Massachusetts General Hospital · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 3 answered